Publications
Where expertise meets impact
Berry doesn’t just follow industry standards — we set them. Our team of award-winning statisticians, journal editors, and regulatory advisors leads the field in Bayesian and adaptive trial design. With research published in The New England Journal of Medicine, JAMA, and The Lancet, we’re driving innovation where it matters most.
Over 90% of our scientists published influential work this past year, advancing adaptive, Bayesian, and platform trial methodology. Our blend of academic rigor, regulatory insight, and real-world experience makes Berry a true authority in modern clinical trials.
Explore our most impactful peer-reviewed publications below.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Journal of Cardiac Failure
Methodology
Endpoints
Navigating Composite Endpoints: Methods and Recommendations for Trial Design and Interpretation
September 5, 2025
2025
DOI: 10.1016/j.cardfail.2025.04.008
BMJ Journals
Infectious Disease
Platform
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
July 15, 2025
2025
DOI: 10.1136/thorax-2024-222488
Science Direct
Sepsis
Stopping Rules
Design and methods of an adaptive trial to test comparative effectiveness of readmission reduction approaches following infection and sepsis hospitalizations (ACCOMPLISH)
June 19, 2025
2025
DOI: 10.1016/j.conctc.2025.101504
ATS
Mechanical Ventilation
Historical Borrowing
Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)
June 11, 2025
2025
DOI: 10.1164/rccm.202505-1056OC
Statistics in Medicine
Methodology
Stopping Rules
Predictive Probabilities Made Simple: A Fast and Accurate Method for Clinical Trial Decision-Making
June 1, 2025
2025
DOI: 10.1002/sim.70120
The Lancet Neurology
Neuroscience
Platform
Safety and efficacy of trehalose in amyotrophic lateral sclerosis (HEALEY ALS Platform Trial): an adaptive, phase 2/3, double-blind, randomised, placebo-controlled trial
June 1, 2025
2025
DOI: 10.1016/S1474-4422(25)00173-5
Wiley Online Library
Neuroscience
Platform
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial. Muscle Nerve.
May 26, 2025
2025
DOI: 10.1002/mus.28442
Springer Nature
Infectious Disease
Meta-analysis
Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis
May 5, 2025
2025
DOI:10.1007/s00134-025-07912-2
No results found.
There are no results with this criteria. Try changing your search.